M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.36 PLN -9.55% Market Closed
Market Cap: 24.5m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note
Section:
 

Relative Value

The Relative Value of one MDB stock under the Base Case scenario is 0.19 PLN. Compared to the current market price of 0.36 PLN, Medicofarma Biotech SA is Overvalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDB Relative Value
Base Case
0.19 PLN
Overvaluation 46%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

18.1
P/S
P/S
Price to Sales
18.1
vs History
14
vs Industry
9
Median 3Y
18.1
Median 5Y
8.6
Industry
4.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-45.5
Median 5Y
-119.4
Industry
32.7
More Details
20.5
P/OCF
P/OCF
Price to OCF
20.5
vs History
33
vs Industry
21
Median 3Y
43.5
Median 5Y
-363.6
Industry
22.1
More Details
28.2
P/FCFE
P/FCFE
Price to FCFE
28.2
vs History
19
vs Industry
16
Median 3Y
6.2
Median 5Y
-822.9
Industry
33.6
More Details
2.5
P/B
P/B
Price to Book Value
2.5
vs History
57
vs Industry
29
Median 3Y
6.3
Median 5Y
5.9
Industry
2.6
More Details
18
EV/S
EV/S
Enterprise Value to Sales
18
vs History
14
vs Industry
9
Median 3Y
18
Median 5Y
8.6
Industry
3.9
More Details
21.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
21.1
vs History
42
vs Industry
11
Median 3Y
53
Median 5Y
26.9
Industry
8.6
More Details
27.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
27.7
vs History
23
vs Industry
9
Median 3Y
35.5
Median 5Y
-968.3
Industry
18.5
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-46.3
Median 5Y
-120
Industry
23.7
More Details
20.4
EV/OCF
EV/OCF
Enterprise Value to OCF
20.4
vs History
33
vs Industry
20
Median 3Y
43.5
Median 5Y
-363.5
Industry
21.4
More Details
20.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.4
vs History
9
vs Industry
23
Median 3Y
-52.7
Median 5Y
-288.7
Industry
28.8
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
57
vs Industry
38
Median 3Y
5.2
Median 5Y
4.7
Industry
2.4
More Details

Multiples Across Competitors

MDB Competitors Multiples
Medicofarma Biotech SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
Medicofarma Biotech SA
WSE:MDB
24.5m PLN 18.1 -22.9 27.7 -23.6
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.3B USD 4.8 33 21.4 30.6
US
Danaher Corp
NYSE:DHR
166.6B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
67T KRW 15.4 63.7 34.5 49.6
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.8B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.3B USD 2.4 25.8 14.2 21.7
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.2
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.4 48.3 32.4 40.7
CN
WuXi AppTec Co Ltd
SSE:603259
162B CNY 4.2 20.2 14.6 14.6

See Also

Summary
MDB intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDB stock valuation using valuation multiples.
Wall Street Estimates
MDB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.